Podlesak Dennis sold SNDX
August 15, 2025 · Form 4 insider transaction
Podlesak Dennis sold 19,200 shares of Syndax Pharmaceuticals, Inc. at $15.54 per share, a transaction worth $298.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person solely covering equity grants with expiration dates prior to August 21, 2025. Following the sales reported in this Form 4, the Reporting Person has a total of 135,000 options to purchase shares of common stock that are vested and immediately exercisable and no unvested options to purchase shares of common stock.; The sale prices ranged from $14.88 to $15.91.